Elawyers Elawyers
Ohio| Change

The City of New Castle v. Purdue Pharma L.P., 18-1472. (2018)

Court: District Court, E.D. Pennsylvania Number: infdco20180718d33 Visitors: 11
Filed: Jul. 16, 2018
Latest Update: Jul. 16, 2018
Summary: ORDER ROBERT F. KELLY , Senior District Judge . AND NOW , this 16th day of July, 2018, upon consideration of the Motion to Remand filed by Plaintiffs, the City of New Castle, City of Aliquippa, and Union Township (Doc. No. 9), Defendants, Teva Pharmaceuticals USA, Inc. and Cephalon, Inc.'s (collectively, "Teva Defendants") Response in Opposition to Plaintiffs' Motion to Remand, which included the argument that the Court should stay this action pending the transfer of the action to the fede
More

ORDER

AND NOW, this 16th day of July, 2018, upon consideration of the Motion to Remand filed by Plaintiffs, the City of New Castle, City of Aliquippa, and Union Township (Doc. No. 9), Defendants, Teva Pharmaceuticals USA, Inc. and Cephalon, Inc.'s (collectively, "Teva Defendants") Response in Opposition to Plaintiffs' Motion to Remand, which included the argument that the Court should stay this action pending the transfer of the action to the federal multidistrict litigation ("MDL") entitled In re Nat'l Prescription Opiate Litig., MDL No. 2804 ("Opiate MDL"), and Plaintiffs' Reply, it is hereby ORDERED that:

1. Plaintiffs' Motion to Remand is DENIED WITHOUT PREJUDICE; 2. Teva Defendants' request for a stay is GRANTED; and 3. all proceedings are STAYED pending the Judicial Panel on Multidistrict Litigation's ("JPML") decision as to whether to transfer this case to the Opiate MDL. The parties shall submit a joint status report within fourteen (14) days of receiving a decision from the JPML.
Source:  Leagle

Can't find what you're looking for?

Post a free question on our public forum.
Ask a Question
Search for lawyers by practice areas.
Find a Lawyer